A Pilot Study of a Response Oriented Chemotherapeutic Regimen Combined with Autologous Peripheral Blood Progenitor Cell Transplantation in Aggressive Non-Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

A Pilot Study of a Response Oriented Chemotherapeutic Regimen Combined with Autologous Peripheral Blood Progenitor Cell Transplantation in Aggressive Non-Hodgkin's Lymphoma

Published:1999-01 Issue:3-4 Volume:34 Page:361-371
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Tarumi Takashi,Sawada Ken-Ichi,Koizumi Kazuki,Takano Hina,Fukada Yoshikazu,Nishio Mitsufumi,Fujie Teiji,Ohnishi Katsunori,Kohno Michifumi,Sato Norihiro,Sekiguchi Sadayoshi,Koike Takao

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199909050961

Reference24 articles.

1. Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma

2. Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

3. Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.

4. Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma

5. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High concentrations of glucose suppress etoposide-induced cell death of B-cell lymphoma through BCL-6;Biochemical and Biophysical Research Communications;2014-07

2. FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin’s lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation;European Journal of Haematology;2009-02

3. Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation;British Journal of Haematology;2007-05

4. Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma;European Journal of Haematology;2006-09

5. A preliminary analysis of the balance between Th1 and Th2 cells after CD34+ cell-selected autologous PBSC transplantation;Cytotherapy;2004-08